Medtronic PLC (MDT) is one of the premier “Big 4” medical device stocks. This high-quality blue-chip dividend growth stock has increased its dividend for 45 consecutive years with no end in sight. Mr. Market normally prices this blue-chip at a premium valuation. However, Medtronic, which started out significantly overvalued in 2022, has recently moved into fair value territory. Consequently, this is a rare opportunity to invest in this A rated dividend growth stock with low debt to capture a dividend yield that is currently over 3%.

In this video, I cover the basic fundamental valuation modalities which indicate a research candidate worthy of conducting a more comprehensive research effort. Additionally, I will illustrate how easy it is to conduct that research effort when you have the proper research tools at your disposal. In short, FAST Graphs make it easier and faster to research a stock than ever before.

SUBSCRIBE to our YouTube Channel!

Try FAST Graphs for FREE:
https://www.fastgraphs.com

Disclaimer: FAST Graphs is a tool designed to reveal and present information related to financial data and investment metrics. It is not intended to provide specific advice or recommendations. Instead, it offers a comprehensive view of relevant data, empowering users to make informed decisions based on their own analysis. It's your first step to a more comprehensive research and due diligence process. In short, it is a tool to think with. The opinions in this video are for informational and educational purposes only and should not be construed as a recommendation to buy or sell the stocks mentioned.

#dividends #stocks #investing